SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-027406
Filing Date
2014-05-05
Accepted
2014-05-05 08:07:44
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v376222_10q.htm 10-Q 422789
2 EXHIBIT 31.1 v376222_ex31-1.htm EX-31.1 11437
3 EXHIBIT 31.2 v376222_ex31-2.htm EX-31.2 11328
4 EXHIBIT 32.1 v376222_ex32-1.htm EX-32.1 4173
5 EXHIBIT 32.2 v376222_ex32-2.htm EX-32.2 4205
  Complete submission text file 0001144204-14-027406.txt   8036410

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mslp-20140331.xml EX-101.INS 1217544
7 XBRL TAXONOMY EXTENSION SCHEMA mslp-20140331.xsd EX-101.SCH 100936
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mslp-20140331_cal.xml EX-101.CAL 69920
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mslp-20140331_def.xml EX-101.DEF 500991
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mslp-20140331_lab.xml EX-101.LAB 564537
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mslp-20140331_pre.xml EX-101.PRE 583568
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

IRS No.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53166 | Film No.: 14811381
SIC: 2834 Pharmaceutical Preparations